Selective Treatment of Cancer: Synthesis, Biological Evaluation and Structural Elucidation of Novel Analogues of the Antibiotic CC‐1065 and the Duocarmycins
Authors:
- Lutz F. TietzeLTLutz F. Tietze
- Dirk A. SpieglDSDirk A. Spiegl
- Birgit KrewerBKBirgit Krewer
- Katja MaksimenkaKMKatja Maksimenka
- Gerhard BringmannGBGerhard Bringmann
- 15 May 2007
- journal article
- research article
- Published by Wiley in Chemistry – A European Journal
- Vol. 13 (16) , 4396-4409
Abstract
Novel diastereomerically pure β‐D‐galactosidic prodrugs (+)‐12 a–e of the cytotoxic antibiotics CC‐1065 and the duocarmycins were prepared for an antibody directed enzyme prodrug therapy (ADEPT) using 4 as a substrate via a radical cyclization to give rac‐5 and rac‐6 followed by a chromatographic resolution of the enantiomers of rac‐5, glycosidation and linkage to the DNA‐binding units 10 a–e. These only slightly toxic compounds can be toxified enzymatically by an antibody–β‐D‐galactosidase conjugate at the surface of malignant cells to give the cytotoxic drugs, which then alkylate DNA. The new prodrugs were tested in in vitro cytotoxicity assays showing excellent QIC50 values of 4800 and 4300 for (+)‐12 a and (+)‐12 b, respectively. The absolute configuration of precursor (+)‐5 was determined by comparison of the experimental CD spectrum with the theoretically predicted CD spectra and by X‐ray structure analysis.Keywords
This publication has 49 references indexed in Scilit:
- Antitumor Agents: Development of Highly Potent Glycosidic Duocarmycin Analogues for Selective Cancer TherapyAngewandte Chemie International Edition, 2006
- Investigation of Reactivity and Selectivity of DNA‐Alkylating Duocarmycin Analogues by High‐Resolution Mass SpectrometryAngewandte Chemie International Edition, 2006
- Antitumor‐Wirkstoffe: Entwicklung hochpotenter glycosidischer Duocarmycin‐Analoga für eine selektive KrebstherapieAngewandte Chemie, 2006
- Untersuchung der Reaktivität und Selektivität DNA-alkylierender Duocarmycin-Analoga mittels hochauflösender MassenspektrometrieAngewandte Chemie, 2006
- Tumor-activated Prodrugs—A New Approach to Cancer TherapyCancer Investigation, 2004
- Ancistrotanzanine A, the First 5,3‘-Coupled Naphthylisoquinoline Alkaloid, and Two Further, 5,8‘-Linked Related Compounds from the Newly Described SpeciesAncistrocladus tanzaniensis,1Journal of Natural Products, 2003
- Examination of the role of the duocarmycin SA methoxy substituents: Identification of the minimum, fully potent DNA binding subunitBioorganic & Medicinal Chemistry Letters, 1996
- A new mixing of Hartree–Fock and local density-functional theoriesThe Journal of Chemical Physics, 1993
- New Methods for the Synthesis of Glycosides and Oligosaccharides—Are There Alternatives to the Koenigs‐Knorr Method? [New Synthetic Methods (56)]Angewandte Chemie International Edition, 1986
- Development and use of quantum mechanical molecular models. 76. AM1: a new general purpose quantum mechanical molecular modelJournal of the American Chemical Society, 1985